Cyclophosphamide
Severe Chronic Active Epstein Barr Virus
Baylor College of MedicineSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Severe Chronic Active Epstein Barr Virus cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Mabel Ctls Baylor College of Medicine | Phase 1 | CC |
Fludarabine Baylor College of Medicine | Phase 1 | CC |
Allogeneic Donor Derived Lmp Specific Cytotoxic T-Lymphocyte Baylor College of Medicine | Phase 1 | C |
Same molecule, other indications
Cyclophosphamide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →